Company Filing History:
Years Active: 2018
Title: The Innovations of Robert Maxey
Introduction
Robert Maxey is a notable inventor based in Harlow, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target inflammatory diseases. His work is characterized by a focus on innovative chemical derivatives that have the potential to improve treatment options for patients.
Latest Patents
Maxey holds a patent for "Pyridazine derivatives as RORc modulators." This patent includes compounds of the formula I or a pharmaceutical salt thereof, wherein X, Ar, R1, R, R, R, R, and R are defined within the patent documentation. The patent also outlines methods for synthesizing these compounds and their applications in treating inflammatory diseases such as arthritis. This innovation highlights his commitment to addressing significant health challenges through scientific research.
Career Highlights
Throughout his career, Robert Maxey has been associated with Genentech, Inc., a leading biotechnology company known for its focus on developing innovative therapies. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to pharmaceutical science.
Collaborations
Maxey has worked alongside talented colleagues, including Monique Bodil Van Niel and Andrew Peter Cridland. These collaborations have fostered a dynamic environment for innovation and have played a crucial role in advancing their shared research goals.
Conclusion
Robert Maxey's contributions to the field of pharmaceuticals, particularly through his patent on pyridazine derivatives, demonstrate his dedication to improving treatment options for inflammatory diseases. His work continues to inspire advancements in medical research and innovation.